AMA News Wire
7 prior authorization terms that drive every doctor to distraction
Nov 9, 2023
Physicians know all too well about the headaches and heartaches associated with prior authorization (PA) in medicine today. Here’s a handy glossary—or perhaps a devil’s dictionary—to help guide you through the folly, with pointers to how the AMA is standing up to insurance companies to eliminate care delays, patient harm and practice hassles.
Prior authorization
Prior authorization
This is a health plan cost-control process that restricts patient access to treatments, drugs and services. This process requires physicians to obtain health plan approval before delivery of the prescribed treatment, test or medical service in order to qualify for payment.
According to an AMA survey (PDF) of 1,001 practicing physicians, 89% of respondents said prior authorization had a significant or somewhat negative clinical impact, with 33% reporting that prior authorization had led to a serious adverse event such as a death, hospitalization, disability or permanent bodily damage, or other life-threatening event for a patient in their care.
The vast majority of physicians (88%) described the administrative burden associated with prior authorization as “high or extremely high,” and physician practices complete an average of 45 prior authorizations per physician per week.
Fixing prior authorization is a critical component of the AMA Recovery Plan for America’s Physicians.
Prior authorization is overused, and existing processes present significant administrative and clinical concerns. Find out how the AMA is tackling prior authorization with research, practice resources and reform resources.
Utilization management
Utilization management
Prior authorization is just one subset of the larger field of insurer practices called utilization management, which the Institute of Medicine—now known as the National Academy of Medicine—defined way back in 1989 as “a set of techniques used by or on behalf of purchasers of health care benefits to manage health care costs by influencing patient care decision-making through case-by-case assessments of the appropriateness of care prior to its provision.” That has a familiar ring to it.
Visit AMA Advocacy in Action to find out what’s at stake in fixing prior authorization and other advocacy priorities the AMA is actively working on.
Step therapy
Step therapy
Another utilization-management technique that can drive doctors to the brink is step therapy, sometimes called the fail-first requirement. Under such a policy, payers will require that patients first try and fail lower-cost tests, drugs or other treatments before moving on to higher-cost options, sometimes in cases when the patient has already unsuccessfully tried the therapy under a previous insurance plan.
Medical necessity
Medical necessity
Everyone agrees that patients should not get a drug, test or surgery unless it is medically needed. The reason why this common utilization-management term drives doctors to distraction is that it seems as though each payer has its own definition of medical necessity, which makes navigating the process highly frustrating for physicians who just want their patients to get the care they deserve.
The AMA believes that what constitutes medically appropriate treatment should be based on clinical guidelines developed by the appropriate national medical specialty society and be consistent regardless of a patient’s insurer. There should be a standard medical necessity definition so that all insurers in a state are playing by the same rules and everyone understands what those rules are.
Learn more about what the AMA’s research has uncovered about prior authorization and share your story to help guide advocacy efforts to fix prior auth.
Peer-to-peer review
Peer-to-peer review
This is a process in which an ordering physician discusses the need for a procedure or drug with another physician who works for the payer in order to obtain a prior authorization approval or appeal a previously denied PA. If properly implemented, the process can be helpful, as it affords the physician the opportunity to speak with another clinician. What frustrates doctors is that it usually comes after days or even weeks of bureaucratic wrangling, and the health plan's “peer” often is from a completely different specialty and knows nothing about the disease or treatment in question.
The AMA says peer-to-peer review should be available at any point following an adverse prior authorization determination, and that the peer to whom the physician speaks should be a genuine peer—a doctor practicing in the same specialty and subspecialty, and licensed in the same state, as the ordering physician.
Standard pharmacy electronic prior authorization
Standard pharmacy electronic prior authorization
Also called ePA, this capability automates prior authorization by integrating it into the physician’s electronic prescribing workflow and can make the PA process faster, consistent across insurers, and more efficient. Unfortunately, physicians interested in using this technology are often stymied, as ePA is far from being the norm.
Too often, physician practices and health care organizations are stuck navigating telephone trees, waiting on hold, or feeding forms into their fax machines. Even when health plans offer electronic prior authorization options, they often involve proprietary portals that require workflow disruption to exit the EHR, logging into the insurer’s unique website, and time-consuming reentry of patient and clinical data—not the streamlined standard ePA process embedded within the EHR. Astoundingly, the Cleveland Clinic has racked up a $10 million annual tally just to push their prior authorization requests through the process.
Learn more about how ePA technology that integrates with practices' current electronic prescribing workflows can improve the drug prior authorization process, just one of the AMA’s prior authorization practice resources.
Gold carding
Gold carding
This is a process under which a payer exempts physicians who consistently order or prescribe treatments and drugs in accordance with evidence-based guidelines, or have high approval rates, from PA requirements. So if you’re not an outlier physician—if your prior authorization requests are approved like clockwork—at, let’s say, a 90% rate—then payers should be happy to grant you that proverbial gold card, allowing you to get your patients quick access to the care towards which they have been paying their premiums.
While Texas has enacted prior authorization “gold card” legislation and a bill in Congress would advance the idea in Medicare Advantage, such programs are not prevalent in health care today, and it is bewildering to doctors that such a commonsense concept—one that would reduce PA burdens for both practices and insurers—hasn’t yet taken hold on a wide scale.
The essential idea was outlined in a set of principles put forth (PDF) by the AMA and 16 other physician, patient and health care organizations.
Moreover, a consensus statement (PDF) released by the AMA and national associations representing medical groups, hospitals and insurers encourages just these sorts of programs to lower the overall volume of PAs by selectively applying these requirements.
The country’s No. 1 health insurer, UnitedHealthCare, has said it plans to implement a national gold-carding program in 2024, but that remains to be seen. As shown above, when it comes to prior authorization, the devil most assuredly is in the details.
